M. Seidel

发表

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

S. Winkler, M. Böhm, P. Erne, 2018, The Lancet.

Molecular diagnosis of a Mycobacterium chelonae infection.

H. Höfler, M. Werner, M. Kremer, 2001, Pathology, research and practice.

Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy

H. Biersack, S. Ezziddin, A. Sabet, 2015, Nuklearmedizin.

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.

F. Fedele, F. Fruhwald, G. Malfatto, 2017, International journal of cardiology.

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

S. Winkler, P. Erne, P. Buser, 2020, The Lancet.

The association of a retroesophageal right subclavian artery, a right-sided terminating thoracic duct, and a left vertebral artery of aortic origin: anatomical and clinical considerations.

H. Nathan, M. Seidel, 1983, Acta anatomica.

Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.

A. Parkhomenko, K. Dickstein, M. Nieminen, 2014, International journal of cardiology.

Rationale and design of the randomised Treatment of sleep apnoea Early After Myocardial infarction with Adaptive Servo-Ventilation trial (TEAM-ASV I)

M. Arzt, F. Zeman, O. Hamer, 2020, Trials.

Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial

T. Friede, B. Pieske, S. Massberg, 2023, Clinical Research in Cardiology.